Chris Brady, PsyD, is a licensed clinical psychologist with over 25 years of clinical experience and over 20 years of rater training experience in the pharmaceutical industry. She has extensive scientific and operational experience and has been responsible for developing, implementing, and overseeing scale training programs, data review and eligibility review across Phase I-IV clinical trials in psychiatry, neurology and analgesia. Dr. Brady works frequently with global thought leaders on scale selection and training.
In clinical practice, Dr. Brady treated and assessed children and adults in school, residential treatment, hospital and outpatient settings. She has administered the full range of neuropsychological testing batteries across the age range to develop diagnoses and treatment plans for individuals with cognitive, developmental, and psychological issues. Dr. Brady was Director of Rater Training at an investigational site where she worked for over five years, administering scales for affective disorder and Alzheimer’s disease clinical trials. Dr. Brady was the Lead Scale Scientist on the first industry sponsored clinical trials in Autism where she worked with key opinion leaders to develop ADI-R and ADOS training programs for clinical research sites which have continued to be used in subsequent trials. She has facilitated advisory board meetings with individuals and their study partners on the topic of clinical trials in the area of Autism Spectrum Disorders and provided protocol consultation related to the information gathered.
Dr. Brady’s special interests include assessing language, protocol development, training on symptom rating scales and diagnostic tools and interviews skills training.